Clinical trial · Interventional
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
Can Narrative Medicine Methods Improve Well-Being in Patients With GI Malignancies
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial assesses whether narrative medicine methods may improve the sense of well-being among gastrointestinal (GI) (digestive system) cancer patients. Narrative medicine is a clinical approach where providers can use a patient's own narrative (perspective) of their illness to promote healing and resilience. By applying narrative medicine's main tool, close reading, to clinical practice, clinicians learn to listen and attend to patients more deeply. This allows for freer communication and the creation of a healthcare encounter that centers on the psychological and emotional well being of the patient in addition to their medical conditions. Narrative medicine can include close reading, creative or reflective writing, and discussion. These methods may help patients with GI cancer to reflect on their life stories, both inside and outside of their illness experience, and help them gather skills to optimize their well-being.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Digestive System Neoplasm | Malignant Digestive System Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Discussion | Procedure | — | UNRESOLVED |
| Interview | Other | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Supportive Care (narrative medicine sessions)
- description
- Patients participate in narrative medicine sessions over 60 minutes Q2W for 3 sessions.
- interventionNames
- Procedure: Discussion
- Other: Interview
- Other: Survey Administration
Primary outcomes (2)
- measure
- Number of participants who complete the narrative medicine sessions
- timeFrame
- Up to 3 months
- description
- To determine the intervention feasibility, the number of participants who complete the narrative medicine sessions will be tracked.
- measure
- Change in well-being scores
- timeFrame
- Up to 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with diagnosis of gastrointestinal malignancy actively receiving infusional therapy for cancer. * Age \>= 18 years. * English speaking with ability to participate in reading and writing questionnaires and implementation tools. * Performance Status =\< Eastern Cooperative Oncology Group (ECOG) 3. Exclusion Criteria: * Altered mental status or other cognitive impairment, organic or drug induced that would limit ability to participate in the evaluation.
References
Publications (0)
Data not yet available